Exavir Therapeutics
Exavir Therapeutics is a New York City-based company founded by Alborz Yazdi, Howard Gendelman and Benson Edagwa.
All edits
Edits on 3 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
SBIR/STTR Awards
Edits on 24 Nov, 2023
Edits on 6 Sep, 2023
Katrina-Kay Pettitt
Edits made to:
Infobox (+1/-1 properties)
Infobox
Number of Employees (Ranges)
5 – 9
Number of Employees (Ranges)
1 – 4
Edits on 31 Jul, 2023
Katrina-Kay Pettitt
Edits on 16 Mar, 2023
Katrina-Kay Pettitt
Katrina-Kay Pettitt
Edits on 9 Mar, 2023
Katrina-Kay Pettitt
Edits on 22 Feb, 2023
Katrina-Kay Pettitt
Edits on 6 Aug, 2022
Andrey Duzenko
Edits made to:
Infobox (+4 properties)
Infobox
Email address
media@exavirtx.com0
Pitchbook URL
Edits on 25 Jul, 2022
Amy Sar
Edits on 16 Jun, 2022
Golden AI
Edits on 23 May, 2022
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Latest funding type
Total funding amount (USD)
4,000,000
Golden AI
Aleksey Pavlov
Edits made to:
Article (+212 characters)
Exavir Therapeutics
Article
Exavir Therapeutics is a preclinical stage biotechnology company dedicated to eliminating HIV and other viral infections with a broad modality-agnostic approach, beginning with long-acting antiviral therapeutics.
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Funding rounds
Aleksey Pavlov
Edits made to:
Infobox (+9 properties)
Infobox
Company Operating Status
Active
Email address
media@exavirtx.com
Industry
Number of Employees (ranges)
5 – 9
Twitter URL
Aleksey Pavlov
Edits made to:
Infobox (+3 properties)
Exavir Therapeutics
Infobox
Website URL
Find more companies like Exavir Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
